Hypori, the innovative mobile access platform provider enabling secure virtual access to enterprise apps and data from any mobile device with total personal privacy, proudly announces the hire of ...

American Airlines has revised its policy regarding booting passengers from planes, potentially making flyers harder to ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...

NEW YORK & TEL AVIV, Israel, November 11, 2024--monday.com (NASDAQ: MNDY), the multi-product platform that runs all core ...

Following the BARDA/RRPV award of nearly $400 million in support of evaluating GEO-CM04S1 in the Project NextGen program, we continue to collaborate closely with the BARDA Project NextGen team and our ...

KEY BUSINESS HIGHLIGHTSPhase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to ...

Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care conditions and community health ...

Back in May 2024, the airline received a federal lawsuit after eight Black male passengers were removed from a flight going ...

"I am thrilled to further strengthen and enrich Ocular's senior leadership team with the appointment of Namrata as Chief ...

Thank you for joining Axon's executive team today. I hope you all had a chance to read our shareholder letter, which was ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Ladies and gentlemen, welcome to the 2024 Q3 Earnings Sprout Social, Incorporated Conference Call. All lines have been placed on mute to ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to improving vision in the real world through ...